AdvanceCor GmbH   Report issue

For profit Phase 2
Founded: Munich Germany (2000)

Organization Overview

First Clinical Trial
2006
NCT01042964
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

AdvanceCor GmbH